Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SERGIO JARAMILLO

Allopathic & Osteopathic Physicians Psychiatry & Neurology Sleep Medicine

NPI
1679770879
CMS profile
121002
Location
MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$5,652.87

172 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 4 of 4; records 151–172 of 172 matching records. This page contains 22 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SERGIO JARAMILLO

NPI 1679770879 · CMS profile ID 121002

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Sleep Medicine

MIAMI, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 4 of 4; records 151–172 of 172 matching records. This page contains 22 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1679770879?year=2025&recipient=provider&page=4#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SERGIO JARAMILLO, NPI 1679770879, CMS profile ID 121002. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–172 of 172 matching records. This page contains 22 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1679770879?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). SERGIO JARAMILLO, NPI 1679770879, CMS profile ID 121002. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 4 of 4; records 151–172 of 172 matching records. This page contains 22 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1679770879?year=2025&recipient=provider&page=4#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
SERGIO JARAMILLO, NPI 1679770879, CMS profile ID 121002, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 4 of 4; records 151–172 of 172 matching records. This page contains 22 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1679770879?year=2025&recipient=provider&page=4#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

172 matching records · $5,652.87 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 172 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 151–172 of 172.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $5.7802/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202116243 CMS
Cycle Pharmaceuticals Inc $19.7602/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248906945 CMS
JAZZ PHARMACEUTICALS INC. $13.1102/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234345699 CMS
ABBVIE INC. $20.3602/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202116241 CMS
Amneal Pharmaceuticals LLC $3.1702/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1220537469 CMS
Neurocrine BioSciences, Inc. $21.0002/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243021973 CMS
ABBVIE INC. $24.2801/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202116239 CMS
UCB, Inc. $47.5101/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1224533481 CMS
Inspire Medical Systems, Inc. $124.4901/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251476971 CMS
Inspire Medical Systems, Inc. $33.8601/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251476973 CMS
PFIZER INC. $14.6801/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230223107 CMS
ABBVIE INC. $13.6201/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202116237 CMS
Lundbeck LLC $20.8701/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1251808351 CMS
Eisai Inc. $21.5601/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244511876 CMS
HARMONY BIOSCIENCES LLC $48.0801/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222392900 CMS
ABBVIE INC. $14.3201/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202116235 CMS
Neurocrine BioSciences, Inc. $21.4801/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243019973 CMS
Teva Pharmaceuticals USA, Inc. $16.8401/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247433069 CMS
ARGENX US, INC. $21.9001/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240421095 CMS
JAZZ PHARMACEUTICALS INC. $14.3101/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234344879 CMS
Tanabe Pharma America, Inc. $29.1501/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1243921868 CMS
Cycle Pharmaceuticals Inc $14.2101/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1248906839 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,459.02 88
PY2020 $2,467.88 124
PY2021 $8,312.60 149
PY2022 $2,805.16 140
PY2023 $6,169.41 179
PY2024 $4,940.20 175
PY2025 $5,652.87 172

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $29,711.17 33
PY2024 Principal investigator $53,427.68 97
PY2023 Recipient $105,822.66 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

33 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Alkermes, Inc. $131.60 12/08/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208613924
Principal investigator 1 Alkermes, Inc. $51.75 12/08/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208617551
Principal investigator 1 Alkermes, Inc. $172.25 12/08/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208617991
Principal investigator 1 Alkermes, Inc. $71.60 12/08/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208620808
Principal investigator 1 Alkermes, Inc. $1,045.00 11/04/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208613121
Principal investigator 1 Alkermes, Inc. $1,196.53 11/03/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208614428
Principal investigator 1 Alkermes, Inc. $70.00 10/31/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208620852
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,392.00 09/10/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743853
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $450.00 07/23/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743859
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $2,200.00 07/11/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743855
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $2,686.20 07/11/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743857
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $2,473.00 07/11/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743861
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $495.56 06/24/2025 Non-covered Recipient Entity
Serenity Research Center
Phase III Safety and Efficacy of KarXT in Psychosis Associated with AD (ADEPT 4): 2 of 2 Acute Studies No dispute reported 06/30/2026 1235993725
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $0.96 06/11/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743841
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $6.72 06/11/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743843
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $16.05 06/11/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743851
Principal investigator 1 Alkermes, Inc. $24.44 06/07/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208622513
Principal investigator 1 Alkermes, Inc. $135.00 06/06/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208613367
Principal investigator 1 Alkermes, Inc. $35.00 06/06/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208614897
Principal investigator 1 Alkermes, Inc. $20.00 06/06/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208615123
Principal investigator 1 Alkermes, Inc. $50.00 06/06/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208615713
Principal investigator 1 Alkermes, Inc. $220.78 06/06/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208619779
Principal investigator 1 Alkermes, Inc. $20.00 06/06/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208621706
Principal investigator 1 Alkermes, Inc. $341.02 06/06/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208626142
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $1,143.00 05/23/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743845
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $560.00 05/23/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743847
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $328.00 05/23/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743849
Principal investigator 1 Alkermes, Inc. $723.91 05/20/2025 Non-covered Recipient Entity
SERENITY RESEARCH CENTER, LLC.
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) No dispute reported 06/30/2026 1208626140
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $13,463.80 03/14/2025 Non-covered Recipient Entity
Serenity Research Center
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimers Disease (ADEPT-4) No dispute reported 06/30/2026 1235993723
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $55.00 01/31/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743833
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $42.00 01/31/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743835
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $55.00 01/31/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743837
Principal investigator 1 JAZZ PHARMACEUTICALS INC. $35.00 01/31/2025 Non-covered Recipient Entity
Serenity Research Center
An Open-Label, Multicenter Switch Study Evaluating Changes in Blood Pressure in Participants With Narcolepsy Switching From High-Sodium Oxybate to XYWAV No dispute reported 06/30/2026 1233743839